Rationale: Obstructive sleep apnea (OSA) is associated with adverse cardiovascular
outcomes, including myocardial infarction and stroke. Atherosclerosis is a key mechanism …

Objective Studies suggest that continuous positive airway pressure (CPAP) therapy may
decrease blood pressure for patients with obstructive sleep apnoea (OSA). However, these …

Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep
apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the …

Obstructive sleep apnea (OSA) is a common disorder that has been associated with an
increased risk of atherosclerosis and its clinical manifestations. While treatment with …

OBJECTIVES: Obstructive sleep apnea (OSA) is associated with significant cardiovascular
(CV) morbidity. Continuous positive airway pressure (CPAP) is the standard treatment for …

Background Obstructive sleep apnea (OSA) is associated with coronary artery disease
(CAD). Intermittent hypoxia associated with OSA increases sympathetic activity and may …

Objectives Obstructive sleep apnea (OSA) and enhanced vascular inflammation coexist in
patients with coronary artery disease (CAD). Continuous positive airway pressure (CPAP) is …

Purpose To evaluate arterial stiffness, a predictor of vascular damage was assessed by
means of pulse wave velocity (PWV) in patients with chronic obstructive pulmonary disease …

Background Obstructive sleep apnea (OSA) is highly prevalent in patients with coronary
artery disease (CAD) and is associated with recurrent cardiovascular risk. However, whether …

Background Millions of individuals with obstructive sleep apnoea (OSA) are treated by
CPAP aimed at reducing blood pressure (BP) and thus cardiovascular risk. However …